Remdesivir is an anti-viral medication and potential treatment for an infection of SARS-CoV-2, which is better known as COVID-19. According to an article written in the Journal of Virus Eradication, the production cost for one day of Remdesivir is estimated to be $0.93 (USD). However, Gilead Sciences Inc. has made the despicable decision to sell each vial of Remdesivir for $390 (USD). This price increases to $520 (USD) a vial for private insurance companies in the USA. At the lower price, one day of Remdesivir will cost $468 (USD).

Gilead Sciences Inc. has decided to profit off of a pandemic which has so far killed 512,000 people across the globe. Sign this petition to make Gilead Sciences Inc. lower the price of this potentially life-saving medication.